Evaluation of Sunscreens Under Actual Use Conditions

NCT02952235 | Completed

• 1 other identifier: CO-151112132858-SACT
• Study Type: interventional
• Target: 199
• Locations: 0 countries
• Sites: N/A

Brief Summary

Use of two high SPF sunscreens under actual use conditions.

Conditions

Sun Protection

Outcome Measures

Primary Outcomes (1)

• Side-by-side Comparison (overall difference) of Sunburn.

  The side-by-side comparison utilized the following condensed two side overall difference scale: L1 = subject's left side noticeably more sunburned than right side, 0= no difference in sunburn, R1= subject's right side noticeably more sunburned than left side. The 0 outcomes were excluded from the analysis.

  Day 2

Secondary Outcomes (1)

• Difference in Erythema Score Between Left and Right Sides at Day 2

  Day 2

Study Arms (2)

SPF50+

OTHER

SPF 50+ assigned to Left side of face SPF 100+ assigned to Right side of face

Other: SPF50+

SPF100+

OTHER

SPF 100+ assigned to Left side of face SPF 50+ assigned to Right side of face

Other: SPF100+

Interventions

SPF50+ OTHER

Sun protection

Also known as: Sunscreens

SPF50+

SPF100+ OTHER

Sun protection

Also known as: Sunscreens

SPF100+

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Males and Females with Fitzpatrick Skin Types I-III
• At least 18 years old
• Able to read, write, speak and understand the English language.
• Has personally read, signed, and dated the Informed Consent Form (including HIPAA disclosure) and Photograph Release
• Generally in good health based on medical history reported by the subject
• Healthy male or female subjects with no history or evidence of clinically relevant medical disorder, as determined from a brief medical history interview.
• Willing and able to follow the study instructions, including:
• Remain outdoors for at least 5 hours on Day 1 during the study with face and neck uncovered (as much as possible)
• Apply the test products (sunscreen) to designated sides of the face and neck
• Remove any make-up, sunscreen, or other facial products at baseline prior to applying test product. Use test product in place of current sun protection topical skincare products (this includes make-up)
• Attend scheduled visits and intend to successfully complete the study
• Return ALL study products at Day 2 exit visit
• Refrain from using other sunscreen products or tanning bed use during the duration of the study.

You may not qualify if:

• Individuals with known allergies or sensitivities to sunscreens or any ingredient contained in the test products or common topical skincare products, including adhesives.
• Observable Sunburn (erythema score above 0.5) on the face and neck as determined by the PI or designee.
• Women known to be pregnant or nursing.
• Individuals with any disease or condition of the skin (e.g., active \[i.e. flaring\] eczema or psoriasis, skin cancer, polymorphic light eruption (PMLE), systemic lupus erythematous (SLE), xerodermapigmentosa) that could interfere with the study or increase risk to the subject.
• Individuals with self-reported UNCONTROLLED metabolic conditions, such as diabetes, hypertension, hyper/hypothyroidism, hypercholesterolemia
• Subjects who are taking medication for chronic conditions that may make a subject more sun sensitive (e.g., Tetracyclines, antifungals, certain diuretics, etc.)
• Skin diseases on tested sites (e.g., photosensitivity disorders, etc.), which may influence the outcome of the study
• Wearing of a full head covered ski mask.
• An individual who has any condition which in the PI's judgment makes the candidate an inappropriate subject for study participation
• Subjects who are related to those persons involved directly or indirectly with the conduct of this study (i.e., PI, sub-investigators, study coordinators, other site personnel, employees of Johnson \& Johnson subsidiaries, contractors of Johnson \& Johnson, and the families of each)
• Individuals with a condition or situation which, in the PI's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
• Individual viewed by the PI as not being able to complete the study

Sponsors & Collaborators

• Johnson & Johnson Consumer and Personal Products Worldwide: lead

MeSH Terms

Interventions

Sunscreening Agents

Intervention Hierarchy (Ancestors)

Radiation-Protective Agents; Protective Agents; Physiological Effects of Drugs; Pharmacologic Actions; Chemical Actions and Uses; Dermatologic Agents; Therapeutic Uses; Cosmetics; Specialty Uses of Chemicals

Study Officials

• Joshua Williams, PhD

  Sponsor GmbH

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 31, 2016
• First Posted: November 2, 2016
• Study Start: March 31, 2016
• Primary Completion: March 31, 2016
• Study Completion: March 31, 2016
• Last Updated: June 8, 2017

Record last verified: 2017-06

Data Sharing

• IPD Sharing: Will not share